Literature DB >> 25336256

Late stages of the synchronized macrophage fusion in osteoclast formation depend on dynamin.

Santosh K Verma1, Evgenia Leikina1, Kamran Melikov1, Leonid V Chernomordik1.   

Abstract

Macrophage fusion that leads to osteoclast formation is one of the most important examples of cell-cell fusion in development, tissue homoeostasis and immune response. Protein machinery that fuses macrophages remains to be identified. In the present study, we explored the fusion stage of osteoclast formation for RAW macrophage-like murine cells and for macrophages derived from human monocytes. To uncouple fusion from the preceding differentiation processes, we accumulated fusion-committed cells in the presence of LPC (lysophosphatidylcholine) that reversibly blocks membrane merger. After 16 h, we removed LPC and observed cell fusion events that would normally develop within 16 h develop instead within 30-90 min. Thus, whereas osteoclastogenesis, generally, takes several days, our approach allowed us to focus on an hour in which we observe robust fusion between the cells. Complementing syncytium formation assay with a novel membrane merger assay let us study the synchronized fusion events downstream of a local merger between two plasma membranes, but before expansion of nascent membrane connections and complete unification of the cells. We found that the expansion of membrane connections detected as a growth of multinucleated osteoclasts depends on dynamin activity. In contrast, a merger between the plasma membranes of the two cells was not affected by inhibitors of dynamin GTPase. Thus dynamin that was recently found to control late stages of myoblast fusion also controls late stages of macrophage fusion, revealing an intriguing conserved mechanistic motif shared by diverse cell-cell fusion processes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25336256      PMCID: PMC6335963          DOI: 10.1042/BJ20141233

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Nanopatterned bulk metallic glass-based biomaterials modulate macrophage polarization.

Authors:  Mahdis Shayan; Jagannath Padmanabhan; Aaron H Morris; Bettina Cheung; Ryan Smith; Jan Schroers; Themis R Kyriakides
Journal:  Acta Biomater       Date:  2018-06-01       Impact factor: 8.947

2.  Myomaker and Myomerger Work Independently to Control Distinct Steps of Membrane Remodeling during Myoblast Fusion.

Authors:  Evgenia Leikina; Dilani G Gamage; Vikram Prasad; Joanna Goykhberg; Michael Crowe; Jiajie Diao; Michael M Kozlov; Leonid V Chernomordik; Douglas P Millay
Journal:  Dev Cell       Date:  2018-09-06       Impact factor: 12.270

3.  Disruption of RAB-5 Increases EFF-1 Fusogen Availability at the Cell Surface and Promotes the Regenerative Axonal Fusion Capacity of the Neuron.

Authors:  Casey Linton; M Asrafuzzaman Riyadh; Xue Yan Ho; Brent Neumann; Rosina Giordano-Santini; Massimo A Hilliard
Journal:  J Neurosci       Date:  2019-02-08       Impact factor: 6.167

4.  Cell-surface phosphatidylserine regulates osteoclast precursor fusion.

Authors:  Santosh K Verma; Evgenia Leikina; Kamran Melikov; Claudia Gebert; Vardit Kram; Marian F Young; Berna Uygur; Leonid V Chernomordik
Journal:  J Biol Chem       Date:  2017-11-03       Impact factor: 5.157

Review 5.  Membrane tension and membrane fusion.

Authors:  Michael M Kozlov; Leonid V Chernomordik
Journal:  Curr Opin Struct Biol       Date:  2015-08-15       Impact factor: 6.809

6.  Conserved pathway activation following xenogeneic, heterotypic fusion.

Authors:  Ce Yuan; Brian T Freeman; Tanner J McArdle; Jangwook P Jung; Brenda M Ogle
Journal:  FASEB J       Date:  2019-02-26       Impact factor: 5.834

7.  Identification of a lipid scrambling domain in ANO6/TMEM16F.

Authors:  Kuai Yu; Jarred M Whitlock; Kyleen Lee; Eric A Ortlund; Yuan Yuan Cui; H Criss Hartzell
Journal:  Elife       Date:  2015-06-09       Impact factor: 8.140

8.  Changing expression profiles of lncRNAs, mRNAs, circRNAs and miRNAs during osteoclastogenesis.

Authors:  Ce Dou; Zhen Cao; Bo Yang; Ning Ding; Tianyong Hou; Fei Luo; Fei Kang; Jianmei Li; Xiaochao Yang; Hong Jiang; Junyu Xiang; Hongyu Quan; Jianzhong Xu; Shiwu Dong
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

9.  Cordycepin Prevents Bone Loss through Inhibiting Osteoclastogenesis by Scavenging ROS Generation.

Authors:  Ce Dou; Zhen Cao; Ning Ding; Tianyong Hou; Fei Luo; Fei Kang; Xiaochao Yang; Hong Jiang; Zhao Xie; Min Hu; Jianzhong Xu; Shiwu Dong
Journal:  Nutrients       Date:  2016-04-20       Impact factor: 5.717

10.  Pannexin-1 and P2X7-Receptor Are Required for Apoptotic Osteocytes in Fatigued Bone to Trigger RANKL Production in Neighboring Bystander Osteocytes.

Authors:  Wing Yee Cheung; J Christopher Fritton; Stacy Ann Morgan; Zeynep Seref-Ferlengez; Jelena Basta-Pljakic; Mia M Thi; Sylvia O Suadicani; David C Spray; Robert J Majeska; Mitchell B Schaffler
Journal:  J Bone Miner Res       Date:  2016-01-20       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.